Unichem Laboratories has announced a leadership shift on its board, signaling a strategic refresh while showcasing continuity in governance. The company disclosed that the term of Independent Director Priti Puri will come to an end on 20 March 2026, with the board recording its gratitude for her meaningful contributions during her tenure.
Effective 21 March 2026, the revised board composition stands as follows: Prakash Mody will serve as Non-Executive & Non-Independent Director and Chairperson; Pranay Godha will be Non-Executive & Non-Independent Director; Pabitrakumar Bhattacharyya will assume the role of Managing Director; Swati Patankar will be a Non-Executive Independent Director; Anand Kusre will be a Non-Executive Independent Director; and Arun Todarwal will join as a Non-Executive Independent Director. This lineup reflects a blend of non-executive chairs and independent oversight alongside the company’s executive leadership.
The move places MD Pabitrakumar Bhattacharyya at the center of the group’s strategic execution, while a slate of Non-Executive and Independent Directors keeps governance anchored in oversight and varied experience. The company’s leadership emphasizes stability and a balanced governance framework as it navigates the evolving landscape of the pharmaceutical sector.
As Unichem advances its strategic priorities, the board refresh underscores a commitment to robust governance and continuity of leadership. The announcement closes with appreciation for Priti Puri’s contributions and a forward-looking view toward a cohesive leadership team aligned with the company’s growth ambitions.